These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 9508651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
    Hahn-Ast C, Glasmacher A, Arns A, Mühling A, Orlopp K, Marklein G, Von Lilienfeld-Toal M.
    Infection; 2008 Feb; 36(1):54-8. PubMed ID: 18193385
    [Abstract] [Full Text] [Related]

  • 4. Tubular disorders in low birth weight neonates after prolonged antibiotic treatment.
    Giapros VI, Papadimitriou FK, Andronikou SK.
    Neonatology; 2007 Feb; 91(2):140-4. PubMed ID: 17344665
    [Abstract] [Full Text] [Related]

  • 5. Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients.
    Malacarne P, Bergamasco S, Donadio C.
    Chemotherapy; 2006 Feb; 52(4):178-84. PubMed ID: 16691027
    [Abstract] [Full Text] [Related]

  • 6. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
    Pauly DJ, Musa DM, Lestico MR, Lindstrom MJ, Hetsko CM.
    Pharmacotherapy; 1990 Feb; 10(6):378-82. PubMed ID: 2287556
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy.
    Ingram PR, Lye DC, Tambyah PA, Goh WP, Tam VH, Fisher DA.
    J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494
    [Abstract] [Full Text] [Related]

  • 8. Vancomycin nephrotoxicity: a review.
    Mergenhagen KA, Borton AR.
    J Pharm Pract; 2014 Dec; 27(6):545-53. PubMed ID: 25266809
    [Abstract] [Full Text] [Related]

  • 9. [Aminoglycosides, risk factors and neonatal kidney].
    Khoory BJ, Fanos V, Dall'Agnola A, Cataldi L.
    Pediatr Med Chir; 1996 Dec; 18(5):495-9. PubMed ID: 9053889
    [Abstract] [Full Text] [Related]

  • 10. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L, Encinas MP, Morín LS, Vilches P, Gutiérrez N, García-Sanz R, Caballero D, Hurlé AD.
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [Abstract] [Full Text] [Related]

  • 11. Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
    Hutschala D, Kinstner C, Skhirdladze K, Thalhammer F, Müller M, Tschernko E.
    Anesthesiology; 2009 Aug; 111(2):356-65. PubMed ID: 19602966
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Fernández de Gatta MD, Calvo MV, Hernández JM, Caballero D, San Miguel JF, Domínguez-Gil A.
    Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
    [Abstract] [Full Text] [Related]

  • 13. Mild nephrotoxicity associated with vancomycin use.
    Downs NJ, Neihart RE, Dolezal JM, Hodges GR.
    Arch Intern Med; 1989 Aug; 149(8):1777-81. PubMed ID: 2764651
    [Abstract] [Full Text] [Related]

  • 14. [Aminoglycoside-induced nephrotoxicity].
    Fabrizii V, Thalhammer F, Hörl WH.
    Wien Klin Wochenschr; 1997 Nov 14; 109(21):830-5. PubMed ID: 9454436
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.
    Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A.
    Eur J Clin Pharmacol; 2012 Sep 14; 68(9):1243-55. PubMed ID: 22411630
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
    Rostas SE, Kubiak DW, Calderwood MS.
    Clin Ther; 2014 Jul 01; 36(7):1098-101. PubMed ID: 24931573
    [Abstract] [Full Text] [Related]

  • 20. Biopsy proven acute tubular necrosis associated with vancomycin in a child: case report and literature review.
    Wu CY, Wang JS, Chiou YH, Chen CY, Su YT.
    Ren Fail; 2007 Jul 01; 29(8):1059-61. PubMed ID: 18067058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.